开发潜在的药理标,以使2型糖尿病患者群岛的基因表达正常化
Viridiana Basaldúa-Maciel1, Fernando Martínez-Esquivias2, Juan Manuel Guzman-Flores3
1Doctorado en Biociencias, Centro Universitario de Los Altos, Universidad de Guadalajara, Tepatitlán de Morelos, Jalisco, México.
Current medicinal chemistry
|April 8, 2025
概括
这项研究确定了2型糖尿病 (T2D) 患者胰腺小岛的分子变化. 生物信息学分析揭示了潜在的药物标和五种实验性药物,以纠正T2D中的基因表达异常.
科学领域:
- 基因组学和生物信息学
- 代谢性疾病 研究 研究 研究
- 药理目标识别法 药理目标识别法
背景情况:
- 2型糖尿病 (T2D) 是一种流行且具有挑战性的代谢障碍,发病率越来越高.
- 现有的T2D药理疗法通常具有有限的疗效,需要新的治疗策略.
- 了解胰腺小岛T2D的分子基础对于开发改进的治疗方法至关重要.
研究的目的:
- 为了确定与T2D相关的胰腺小岛的分子变化.
- 整合多学科数据,以全面了解T2D病原性.
- 使用生物信息学发现T2D治疗的潜在药理学标和候选药物.
主要方法:
- 使用OmicsNet进行多omics数据集成,分析T2D相关的分子变化.
- 蛋白质与蛋白质相互作用网络可视化,基因本体学和KEGG通路分析.
- 实验药物的虚拟查与已识别的枢纽基因和使用CB-Dock2.2的分子对接.
主要成果:
- 在T2D胰腺小岛的关键分子变化包括酶结合,线粒体代谢和转录因子失调.
- 这些变化会影响关键路径,如葡萄糖吸收,胰岛素信号和分泌.
- 分子对接确定了SRC,AKT1,CREBBP和HSP90AA1作为五种特定实验药物的治疗标 (DB02729,DB04877,DB07970,DB07789,DB03373).
结论:
- 该研究确定了T2D患者胰腺的显著分子变化.
- 十个枢纽基因和五种实验药物被确定为T2D的潜在治疗干预措施.
- 需要进一步的研究来验证这些发现及其临床适用性.
相关概念视频
Glucagon-like Receptor Agonists
272
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
272
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Diabetes Mellitus: Overview and Type I Subtype
2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Diabetes: Management and Pharmacotherapy
214
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
214
Cell Specific Gene Expression
13.3K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.3K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.0K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.0K


